GSK completes buyout of Novartis from joint venture

07-06-2018

GSK completes buyout of Novartis from joint venture

Xesai / iStockphoto.com

GSK has confirmed that its $13 billion buyout of Novartis from the companies’ consumer healthcare joint venture has been completed following approval from shareholders.


GSK, Novartis, joint venture, consumer healthcare joint venture, Emma Walmsley

LSIPR